Antimyogenic effect of SARS-CoV spike protein in C2C12 myoblasts

0Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

Abstract

C2C12 myoblasts serve as well-established model system to study myogenesis, as they fuse to form multinucleated myotubes. Severe acute respiratory syndrome coronavirus (SARS-CoV) spike (S) protein plays a crucial role in viral entry. Exogenous expression of S protein in C2C12 myoblasts inhibits the formation of myotubes. Global changes in gene expression were studied in C2C12 cells expressing S protein using oligonucleotide microarray analysis. The expression profile showed that, most of the myogenic marker genes were downregulated. Next, we used RT-PCR analysis to reexamine some downregulated and upregulated genes. To further study the antimyogenic effects induced by the S protein, we introduced antisense Plf (proliferin), an upregulated gene, into the antimyogenic cells. Antisense Ace2 (angiotensin-converting enzyme 2), the cellular receptor of S protein, was also introduced into C2C12 myoblasts. Results indicated that antimyogenic effect induced by S protein was partially rescued in cells expressing antisense Plf, while C2C12 cells expressing antisense Ace2 showed upregulation of Plf. © Chou et al.

Author supplied keywords

Cite

CITATION STYLE

APA

Chou, C. F., Mahadevappa, G., Hong, W., & Tan, Y. J. (2009). Antimyogenic effect of SARS-CoV spike protein in C2C12 myoblasts. Open Infectious Diseases Journal, 3(1), 21–26. https://doi.org/10.2174/1874279300903010021

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free